 The intervention under investigation must be administered before consent from the subjects' legally authorized representatives is feasible; and (iii) There is no reasonable way to identify prospectively the individuals likely to become eligible for participation...  Oversight of NIH and FDA: Bioethics and the Adequacy of Informed Consent ... - Page 91by United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on Human Resources - 1997 - 228 pagesFull view - About this book
 | Administrative law - 2000 - 544 pages
...administered before consent from the subjects' legally authorized representatives is feasible; and (iii) There is no reasonable way to identify prospectively...likely to become eligible for participation in the clinical investigation. (3) Participation in the research holds out the prospect of direct benefit... | |
 | Administrative law - 2001 - 524 pages
...prospectively the individuals likely to become eligible for participation in the clinical investigation. (3) Participation in the research holds out the prospect of direct benefit to the subjects because: (i) Subjects are facing a life-threatening situation that necessitates intervention; (ii) Appropriate... | |
 | Administrative law - 1999 - 508 pages
...prospectively the individuals likely to become eligible for participation in the clinical investigation. (3) Participation in the research holds out the prospect of direct benefit to the subjects because: (i) Subjects are facing a life-threatening situation that necessitates intervention; (ii) Appropriate... | |
 | United States. Congress. House. Committee on Government Reform and Oversight - Law - 1998 - 238 pages
...representative because the intervention must be administered before they could feasibly be reached, ind there is no reasonable way to identify prospectively...research are reasonable in light of what is known 30 about til* condition, the risks and the benefits of current therapy, and what is known about the... | |
 | Baruch A. Brody - Medical - 1998 - 412 pages
...administered before consent from the subjects' legally authorized representatives is feasible; and (iii) There is no reasonable way to identify prospectively...likely to become eligible for participation in the clinical investigation. (3) Participation in the research holds out the prospect of direct benefit... | |
 | Trevor Smith - Medical - 1999 - 428 pages
...in the research must be administered before consent from the patient's next of kin is feasible; (c) there is no reasonable way to identify prospectively...research holds out the prospect of direct benefit to the patients because: (a) patients are facing a life-threatening situation that necessitates intervention;... | |
 | Nancy M. P. King, Gail Henderson, Jane Stein - Medical - 1999 - 300 pages
...administered before consent from the subjects' legally authorized representatives is feasible; and iii) There is no reasonable way to identify prospectively...likely to become eligible for participation in the clinical investigation. 3. Participation in the research holds out the prospect of direct benefit to... | |
 | Daniel Farb, Bruce Gordon - Medical - 2005 - 337 pages
...representatives is feasible. C. The subjects oversleep on the morning of the consent interview. D. There is no reasonable way to identify prospectively...likely to become eligible for participation in the clinical investigation. Answer: C. Authentication accepted! Suddenly Michele was face-to-face with... | |
 | Elizabeth A. Bankert, Robert J. Amdur - Institutional review boards (Medicine) - 2006 - 568 pages
...administered before consent from the subjects' legally authorized representatives is feasible; and (iii) There is no reasonable way to identify prospectively...likely to become eligible for participation in the clinical investigation. (3) Participation in the research holds out the prospect of direct benefit... | |
| |
